Center for Financial Planning’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$58.2K Hold
494
0.01% 284
2025
Q4
$80.9K Hold
494
0.01% 255
2025
Q3
$66K Hold
494
0.01% 272
2025
Q2
$61.4K Buy
494
+126
+34% +$16K 0.01% 274
2025
Q1
$46.8K Buy
368
+193
+110% +$29.7K 0.01% 285
2024
Q4
$25.2K Hold
175
﹤0.01% 324
2024
Q3
$26K Hold
175
﹤0.01% 311
2024
Q2
$22.1K Hold
175
﹤0.01% 316
2024
Q1
$32.2K Hold
175
﹤0.01% 286
2023
Q4
$31.5K Hold
175
0.01% 271
2023
Q3
$27.8K Hold
175
0.01% 274
2023
Q2
$24.8K Hold
175
0.01% 303
2023
Q1
$29.5K Hold
175
0.01% 267
2022
Q4
$29.6K Hold
175
0.01% 262
2022
Q3
$33K Hold
175
0.01% 246
2022
Q2
$28K Hold
175
0.01% 265
2022
Q1
$33K Hold
175
0.01% 261
2021
Q4
$46K Hold
175
0.01% 238
2021
Q3
$51K Hold
175
0.01% 218
2021
Q2
$35K Hold
175
0.01% 252
2021
Q1
$34K Hold
175
0.01% 251
2020
Q4
$34K Buy
+175
New +$31.8K 0.01% 238

Other funds holding RGEN

Center for Financial Planning's RGEN Position: Q1 2026 in Review

Center for Financial Planning held its Repligen (RGEN) position steady in Q1 2026 at 494 shares worth $58.2K. The position accounts for 0.01% of the portfolio, ranked #284.

Center for Financial Planning first reported a position in RGEN in Q4 2020 and has held it in 22 quarters since. The position peaked at $80.9K in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Center for Financial Planning held 494 shares of Repligen worth $58.2K as of Q1 2026.
  • Center for Financial Planning left its Repligen share count unchanged in Q1 2026.
  • Repligen made up 0.01% of Center for Financial Planning's portfolio in Q1 2026, its #284 holding.
  • Center for Financial Planning first reported a position in Repligen in Q4 2020 and has held it in 22 quarters since.
  • Center for Financial Planning's Repligen position peaked at $80.9K in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Center for Financial Planning's 13F filing for Q1 2026, filed 4 May 2026.